Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity

Benedetta Riva, Michela Bellini, Eleonora Corvi, Paolo Verderio, Ewa Rozek, Barbara Colzani, Svetlana Avvakumova, Annalisa Radeghieri, Maria Antonietta Rizzuto, Carlo Morasso, Miriam Colombo, Davide Prosperi

Research output: Contribution to journalArticle

Abstract

Nanoparticles are normally classified as "hard", mainly consisting of metal or metal oxide cores, or "soft", including polymer-based, liposomes and biomimetic nanoparticles. Soft nanoparticles have been studied in depth for drug formulation and therapeutic delivery applications, albeit hard nanoparticles may offer easier synthesis, smaller size and more effective tumor penetration. Among them, silica nanoparticles maintain excellent biocompatibility and biodegradability and can be finely adjusted in size and shape, easily produced in a large scale and functionalized or loaded with active molecules. To help filling the gap of a poor clinical translation of hard nanoparticles, we have designed and developed three different nonporous silica nanocarriers loading the chemotherapeutic doxorubicin within the core matrix, on the surface or both inside and outside, respectively. A comparative study was performed on drug loading and drug release, silica matrix degradation and nanodrug cytotoxic activity, highlighting unexpected correlation between the strategy adopted for drug incorporation and nanoparticle behavior in a physiological environment. This study offers a new insight on the impact of the choice of the prodrug nanoparticles on the kinetics and efficacy of drug delivery, which may encourage the scientific community in developing a new generation of drug delivery systems based on hard nanocarriers.

Original languageEnglish
Pages (from-to)18-26
Number of pages9
JournalJournal of Colloid and Interface Science
Volume519
DOIs
Publication statusPublished - Jun 1 2018

Fingerprint

Silicon Dioxide
Silica
Nanoparticles
Pharmaceutical Preparations
Metals
Liposomes
Biodegradability
Prodrugs
Biomimetics
Drug delivery
Biocompatibility
Doxorubicin
Oxides
Tumors
Polymers
Degradation
Molecules
Kinetics

Cite this

Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity. / Riva, Benedetta; Bellini, Michela; Corvi, Eleonora; Verderio, Paolo; Rozek, Ewa; Colzani, Barbara; Avvakumova, Svetlana; Radeghieri, Annalisa; Rizzuto, Maria Antonietta; Morasso, Carlo; Colombo, Miriam; Prosperi, Davide.

In: Journal of Colloid and Interface Science, Vol. 519, 01.06.2018, p. 18-26.

Research output: Contribution to journalArticle

Riva, B, Bellini, M, Corvi, E, Verderio, P, Rozek, E, Colzani, B, Avvakumova, S, Radeghieri, A, Rizzuto, MA, Morasso, C, Colombo, M & Prosperi, D 2018, 'Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity', Journal of Colloid and Interface Science, vol. 519, pp. 18-26. https://doi.org/10.1016/j.jcis.2018.02.040
Riva, Benedetta ; Bellini, Michela ; Corvi, Eleonora ; Verderio, Paolo ; Rozek, Ewa ; Colzani, Barbara ; Avvakumova, Svetlana ; Radeghieri, Annalisa ; Rizzuto, Maria Antonietta ; Morasso, Carlo ; Colombo, Miriam ; Prosperi, Davide. / Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity. In: Journal of Colloid and Interface Science. 2018 ; Vol. 519. pp. 18-26.
@article{9bf714fbb9ab4134858f218e60954c01,
title = "Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity",
abstract = "Nanoparticles are normally classified as {"}hard{"}, mainly consisting of metal or metal oxide cores, or {"}soft{"}, including polymer-based, liposomes and biomimetic nanoparticles. Soft nanoparticles have been studied in depth for drug formulation and therapeutic delivery applications, albeit hard nanoparticles may offer easier synthesis, smaller size and more effective tumor penetration. Among them, silica nanoparticles maintain excellent biocompatibility and biodegradability and can be finely adjusted in size and shape, easily produced in a large scale and functionalized or loaded with active molecules. To help filling the gap of a poor clinical translation of hard nanoparticles, we have designed and developed three different nonporous silica nanocarriers loading the chemotherapeutic doxorubicin within the core matrix, on the surface or both inside and outside, respectively. A comparative study was performed on drug loading and drug release, silica matrix degradation and nanodrug cytotoxic activity, highlighting unexpected correlation between the strategy adopted for drug incorporation and nanoparticle behavior in a physiological environment. This study offers a new insight on the impact of the choice of the prodrug nanoparticles on the kinetics and efficacy of drug delivery, which may encourage the scientific community in developing a new generation of drug delivery systems based on hard nanocarriers.",
author = "Benedetta Riva and Michela Bellini and Eleonora Corvi and Paolo Verderio and Ewa Rozek and Barbara Colzani and Svetlana Avvakumova and Annalisa Radeghieri and Rizzuto, {Maria Antonietta} and Carlo Morasso and Miriam Colombo and Davide Prosperi",
note = "Copyright {\circledC} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.jcis.2018.02.040",
language = "English",
volume = "519",
pages = "18--26",
journal = "Journal of Colloid and Interface Science",
issn = "0021-9797",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity

AU - Riva, Benedetta

AU - Bellini, Michela

AU - Corvi, Eleonora

AU - Verderio, Paolo

AU - Rozek, Ewa

AU - Colzani, Barbara

AU - Avvakumova, Svetlana

AU - Radeghieri, Annalisa

AU - Rizzuto, Maria Antonietta

AU - Morasso, Carlo

AU - Colombo, Miriam

AU - Prosperi, Davide

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Nanoparticles are normally classified as "hard", mainly consisting of metal or metal oxide cores, or "soft", including polymer-based, liposomes and biomimetic nanoparticles. Soft nanoparticles have been studied in depth for drug formulation and therapeutic delivery applications, albeit hard nanoparticles may offer easier synthesis, smaller size and more effective tumor penetration. Among them, silica nanoparticles maintain excellent biocompatibility and biodegradability and can be finely adjusted in size and shape, easily produced in a large scale and functionalized or loaded with active molecules. To help filling the gap of a poor clinical translation of hard nanoparticles, we have designed and developed three different nonporous silica nanocarriers loading the chemotherapeutic doxorubicin within the core matrix, on the surface or both inside and outside, respectively. A comparative study was performed on drug loading and drug release, silica matrix degradation and nanodrug cytotoxic activity, highlighting unexpected correlation between the strategy adopted for drug incorporation and nanoparticle behavior in a physiological environment. This study offers a new insight on the impact of the choice of the prodrug nanoparticles on the kinetics and efficacy of drug delivery, which may encourage the scientific community in developing a new generation of drug delivery systems based on hard nanocarriers.

AB - Nanoparticles are normally classified as "hard", mainly consisting of metal or metal oxide cores, or "soft", including polymer-based, liposomes and biomimetic nanoparticles. Soft nanoparticles have been studied in depth for drug formulation and therapeutic delivery applications, albeit hard nanoparticles may offer easier synthesis, smaller size and more effective tumor penetration. Among them, silica nanoparticles maintain excellent biocompatibility and biodegradability and can be finely adjusted in size and shape, easily produced in a large scale and functionalized or loaded with active molecules. To help filling the gap of a poor clinical translation of hard nanoparticles, we have designed and developed three different nonporous silica nanocarriers loading the chemotherapeutic doxorubicin within the core matrix, on the surface or both inside and outside, respectively. A comparative study was performed on drug loading and drug release, silica matrix degradation and nanodrug cytotoxic activity, highlighting unexpected correlation between the strategy adopted for drug incorporation and nanoparticle behavior in a physiological environment. This study offers a new insight on the impact of the choice of the prodrug nanoparticles on the kinetics and efficacy of drug delivery, which may encourage the scientific community in developing a new generation of drug delivery systems based on hard nanocarriers.

U2 - 10.1016/j.jcis.2018.02.040

DO - 10.1016/j.jcis.2018.02.040

M3 - Article

C2 - 29477896

VL - 519

SP - 18

EP - 26

JO - Journal of Colloid and Interface Science

JF - Journal of Colloid and Interface Science

SN - 0021-9797

ER -